Prof. Roberto Bolli, M.D., D.Sc. (Hon)

Prof. Roberto Bolli, M.D., D.Sc. (Hon)

Director of the Institute of Molecular Cardiology, University of Louisville Louisville, KY, USA


Professor of Medicine and Physiology

Distinguished University Scholar

Legacy Foundation of Kentuckiana Distinguished Chair in Cardiology

Editor-in-Chief, Molecular and Cellular Biochemistry

Past President, International Academy of Cardiovascular Sciences

Principal Investigator, DoD CATO Trial PR22116

Former Editor-in-Chief, Circulation Research       

Former President, International Society for Heart Research 

Former President, Council on Basic Sciences of the American Heart Association, etc.

H index is 130, publications >500, and total citations >61,000. Over the past 45 years, Dr. Bolli’s research has focused on the mechanisms responsible for myocardial ischemia/reperfusion injury and on the development of cardioprotective strategies. His earlier work established a fundamental role of reactive oxygen species in the pathogenesis of myocardial “stunning”. Subsequently, he identified the signal transduction pathways and the cardioprotective genes responsible for the late phase of myocardial “preconditioning. He discovered that the cardioprotection afforded by preconditioning is mediated by two proteins (inducible NO synthase and cyclooxygenase-2. Over the past two decades, he has investigated the use of cell therapy to repair injured myocardium. Professor Bolli was the first to show that, contrary to commonly accepted ideas, transplanted stem/progenitor cells do not engraft in the heart and, work via paracrine actions. This concept has changed our understanding of cell therapy.

Why you should learn from us

Premium Study


Distinguished Professors
and Experts


and Conferences

© 2022-2024 Intercedu. All rights reserved.

Last update: 19.04.2024